戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 203作成日:2026年10月23日

1-Methylpiperazine → N-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamide

https://huagongshe.com/ja/reaction/203

反応式

関与物質

役割名称HCID仕込み量
反応物1-MethylpiperazineHCID 53167—
反応物N-(5-Bromopyrazin-2-YL)acetamideHCID 58574049—
試薬Potassium tert-butoxideHCID 23665647—
触媒Tris(1,1-dimethylethyl)phosphineHCID 83681—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒DimethylformamideHCID 6228—
生成物N-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamideHCID 5998394179.51%

反応条件

温度120 °C

反応手順

1-methylpiperazine (2.318 g, 23.14 mmol), N-(5-bromopyrazin-2-yl)acetamide (1 g, 4.63 mmol), tri-tert-butylphosphine (1.873 g, 9.26 mmol), tris(dibenzylideneacetone)dipalladium (0.085 g, 0.09 mmol) and potassium 2-methylpropan-2-olate (1.039 g, 9.26 mmol) were suspended in DMF (9.26 ml) and sealed into a microwave tube. The reaction was heated to 120 °C for 40 minutes in the microwave reactor and cooled to RT. The mixture was diluted with methanol and acidified with HCl, then the solution was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford N-(5-(4-methylpiperazin-1-yl)pyrazin-2-yl)acetamide (0.866 g, 80 %) as a dark oil. Used without further purification.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-96727602adb24b28af9c737e24f7315c
出典メモ750 AstraZeneca ELN dataset